Cancer Res Treat.  2019 Apr;51(2):431-437. 10.4143/crt.2019.139.

Prediction of Cancer Incidence and Mortality in Korea, 2019

Affiliations
  • 1The Korea Central Cancer Registry, National Cancer Center, Goyang, Korea. astra67@ncc.re.kr
  • 2National Cancer Control Institute, National Cancer Center, Goyang, Korea.
  • 3Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
  • 4Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.

Abstract

PURPOSE
This study aimed to report on cancer incidence and mortality for the year 2019 to estimate Korea's current cancer burden.
MATERIALS AND METHODS
Cancer incidence data from 1999 to 2016 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2017 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observed age-specific cancer rates against observed years, then multiplying the projected age-specific rates by the age-specific population. The Joinpoint regression model was used to determine at which year the linear trend changed significantly; we used only the data of the latest trend.
RESULTS
A total of 221,347 new cancer cases and 82,344 cancer deaths are expected to occur in Korea in 2019. The most common cancer sites thus far have been the lung, followed by the stomach, colon and rectum, breast, and liver. These five cancers represent half of the overall burden of cancer in Korea. For cancer associated mortality, the most common sites were lung, followed by the liver, colon and rectum, stomach, and pancreas.
CONCLUSION
The incidence rate of all cancer in Korea is estimated to decrease gradually. These up-todate estimates of the cancer burden in Korea could be an important resource for planning and evaluating cancer-control programs.

Keyword

Incidence; Mortality; Neoplasms; Forecasting; Korea; 2019

MeSH Terms

Breast
Colon
Forecasting
Incidence*
Korea*
Linear Models
Liver
Lung
Mortality*
Pancreas
Rectum
Stomach

Figure

  • Fig. 1. The 10 leading types of estimated new cancer cases and deaths by sex in 2019. (A) Estimated new cases. (B) Estimated deaths.

  • Fig. 2. Projected age-specific incidences of major cancers during 2019 in Korea. (A) Male. (B) Female.

  • Fig. 3. Projected age-specific mortality rates of major cancers during 2019 in Korea. (A) Male. (B) Female.


Cited by  16 articles

Relationship between Mothers' Diagnosis of Cervical Cancer and Attitudes toward Preventing Cervical Cancer in Their Pubertal Daughters
Da Bit Lee, Hae Won Kim
Korean J Women Health Nurs. 2019;25(4):434-445.    doi: 10.4069/kjwhn.2019.25.4.434.

Pathologic discrepancies between colposcopy-directed biopsy and loop electrosurgical excision procedure of the uterine cervix in women with cytologic high-grade squamous intraepithelial lesions
Se Ik Kim, Se Jeong Kim, Dong Hoon Suh, Kidong Kim, Jae Hong No, Yong Beom Kim
J Gynecol Oncol. 2020;31(2):.    doi: 10.3802/jgo.2020.31.e13.

Epidemiology of liver cancer in Korea
Sun-Seog Kweon
J Korean Med Assoc. 2019;62(8):416-423.    doi: 10.5124/jkma.2019.62.8.416.

From Genetic Testing to Treatment and Prevention of BRCA-Related Breast Cancer
Chang-Seok Ki
Ann Lab Med. 2020;40(2):99-100.    doi: 10.3343/alm.2020.40.2.99.

Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea
Musaed Rayzah, Jai Min Ryu, Jun-Hee Lee, Seok Jin Nam, Seok Won Kim, Se Kyung Lee, Jonghan Yu, Kyeong-Tae Lee, Sa-Ik Bang, Goo-Hyun Mun, Jai-Kyong Pyon, Byung-Joon Jeon, Jeong Eon Lee
J Korean Med Sci. 2021;36(29):e194.    doi: 10.3346/jkms.2021.36.e194.

12년의 무병기간과 드문 장기 생존기간을 보인 위암 환자에서 발견된 반지세포암종의 골과 골수 전이의 1예
Hyung Woo Kim, Mi Jin Gu, Jong Ho Lee
Lab Med Online. 2021;11(4):305-310.    doi: 10.47429/lmo.2021.11.4.305.

Guidelines for accreditation of endoscopy units: quality measures from the Korean Society of Coloproctology
Rumi Shin, Seongdae Lee, Kyung-Su Han, Dae Kyung Sohn, Sang Hui Moon, Dong Hyun Choi, Bong-Hyeon Kye, Hae-Jung Son, Sun Il Lee, Sumin Si, Won-Kyung Kang
Ann Surg Treat Res. 2021;100(3):154-165.    doi: 10.4174/astr.2021.100.3.154.

Pretreatment Lymph Node Metastasis as a Prognostic Significance in Cervical Cancer: Comparison between Disease Status
Soo Young Jeong, Hyea Park, Myeong Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Tae Joong Kim, Jeong Won Lee, Byoung-Gie Kim, Duk Soo Bae, Chel Hun Choi
Cancer Res Treat. 2020;52(2):516-523.    doi: 10.4143/crt.2019.328.

Laparoscopic Surgery for Colorectal Cancer in Korea: Nationwide Data from 2013 to 2018
Sun Jin Park, Kil Yeon Lee, Suk-Hwan Lee
Cancer Res Treat. 2020;52(3):938-944.    doi: 10.4143/crt.2020.043.

The Fear of Cancer from the Standpoint of Oneself, the Opposite Sex and the Fear of Side Effects of Cancer Treatment
Keeho Park, Youngae Kim, Hyung Kook Yang, Hye Sook Min
Cancer Res Treat. 2020;52(4):993-1001.    doi: 10.4143/crt.2020.285.

Trends in Chemotherapy Patterns and Survival of Patients with Advanced Gastric Cancer over a 16-Year Period: Impact of Anti-HER2–Targeted Agent in the Real-World Setting
Dong-Hoe Koo, Min-Hee Ryu, Mi-Yeon Lee, Heejung Chae, Eo Jin Kim, Mee-Sun Moon, Yoon-Koo Kang
Cancer Res Treat. 2021;53(2):436-444.    doi: 10.4143/crt.2020.725.

Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19
Tung Hoang, Trung Quang Nguyen, Tho Thi Anh Tran
Cancer Res Treat. 2021;53(3):650-656.    doi: 10.4143/crt.2020.950.

Cost Utility Analysis of a Pilot Study for the Korean Lung Cancer Screening Project
Juyoung Kim, Bogeum Cho, Seon-Ha Kim, Chang-Min Choi, Yeol Kim, Min-Woo Jo
Cancer Res Treat. 2022;54(3):728-736.    doi: 10.4143/crt.2021.480.

Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea
Hyeong Min Park, Young-Joo Won, Mee Joo Kang, Sang-Jae Park, Sun-Whe Kim, Kyu-Won Jung, Sung-Sik Han
J Korean Med Sci. 2022;37(28):e216.    doi: 10.3346/jkms.2022.37.e216.

Quality of Life of Survivors of Thyroid Cancer Is Not Inferior to That in Subjects without Cancer: Long-Term after Over 5 Years
Jeongmin Lee, Youn-Ju Lee, Dong-Jun Lim, Jung-Min Lee, Sang-Ah Chang, Min-Hee Kim
Endocrinol Metab. 2022;37(4):664-673.    doi: 10.3803/EnM.2022.1499.

Cost-effective BRCA Testing in Advanced Ovarian Cancer
Myungshin Kim
Ann Lab Med. 2023;43(1):3-4.    doi: 10.3343/alm.2023.43.1.3.


Reference

References

1. Statistics Korea [Internet]. Daejeon: Statistics Korea;2019. [cited 2019 Feb 8]. Available from: http://kosis.kr.
2. Jung KW, Won YJ, Kong HJ, Lee ES; Community of Population-Based Regional Cancer Registries. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat. 2018; 50:303–16.
Article
3. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. Cancer Res Treat. 2005; 37:325–31.
Article
4. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. 1st rev. ed. Geneva: World Health Organization;2013.
5. World Health Organization. International statistical classification of diseases and related health problems. 10th rev. ed. Geneva: World Health Organization;1994.
6. Boyle P, Parkin DM. Statistical methods for registries. In : Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, editors. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon: International Agency for Research on Cancer;1991. p. 126–58.
7. National Cancer Institute. Joinpoint regression program, version 4.3.1 [Internet]. Bethesda, MD: National Cancer Institute;2016. [cited 2019 Feb 8]. Available from: http://surveillance.cancer.gov/joinpoint/.
8. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai: Tohoku University School of Medicine;1960.
Full Text Links
  • CRT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr